Leadership Overview
Santa Farma has 4 executives leading key functions including strategy, marketing, business development, and finance.
Driven by a commitment to modern manufacturing excellence, Santa Farma delivers high-quality pharmaceutical solutions across Turkey. This organization prioritizes human health through rigorous development standards and strategic multinational collaborations that define the current healthcare landscape.
Driven by a commitment to modern manufacturing excellence, Santa Farma delivers high-quality pharmaceutical solutions across Turkey. This organization prioritizes human health through rigorous development standards and strategic multinational collaborations that define the current healthcare landscape.
Leadership Roles at Santa Farma
Sami Kiresepi - Chief Executive Officer
Sami Kiresepi, the Chief Executive Officer at Santa Farma, directs the overarching corporate strategy and long-term vision for the pharmaceutical enterprise. Kiresepi oversees the integration of modern manufacturing techniques with the company's core mission of improving patient outcomes. By fostering multinational collaborations, the Chief Executive Officer expands the reach of the firm within the competitive Turkish healthcare market. This leadership role involves constant evaluation of operational efficiency and the alignment of internal resources with global industry standards. Sami Kiresepi maintains a focus on rational strength and organizational development to ensure sustainable growth. Through the management of high-level partnerships, the Chief Executive Officer secures the company's reputation for trust and quality. Kiresepi drives the executive team toward achieving excellence in every facet of pharmaceutical production, ensuring that the firm remains a leader in the sector while upholding the highest standards of professional integrity and societal responsibility.
Esra Atış - Director, Finance & Chief Financial Officer
Esra Atış, the Director, Finance & Chief Financial Officer at Santa Farma, manages the fiscal health and economic strategy of the organization. Atış directs all financial planning, budgeting, and reporting processes to ensure the company maintains a robust capital structure. As the Director, Finance & Chief Financial Officer, Atış oversees the allocation of resources to support modern manufacturing initiatives and research development. This leadership role involves providing critical financial insights to the Board to guide investment decisions and operational scaling. Esra Atış monitors economic indicators to mitigate risks and optimize the company's financial performance in the volatile pharmaceutical sector. By maintaining strict fiscal discipline, the Director, Finance & Chief Financial Officer ensures that the firm possesses the necessary liquidity to pursue growth opportunities. Atış drives the financial strategy to support the company's commitment to quality and innovation, ensuring that all business activities remain aligned with the long-term financial objectives of the organization.
Tugce Bespinar - Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist
Tugce Bespinar, the Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist at Santa Farma, manages the strategic promotion of pharmaceutical products while overseeing critical quality assurance protocols. Bespinar directs the transfer of manufacturing operations to ensure seamless production cycles that meet international regulatory requirements. By bridging the gap between marketing initiatives and technical quality standards, the Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist optimizes the delivery of medications to healthcare professionals. Tugce Bespinar monitors market trends to refine the company's outreach strategies, ensuring that all promotional activities reflect the firm's commitment to sensitivity and development. This role requires constant coordination with production teams to maintain the highest levels of product safety and efficacy. Through meticulous oversight of manufacturing transfers, the Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist guarantees that the company maintains its competitive edge in the pharmaceutical industry.
Derya Arslan - Business Development Manager & Chief Marketing Officer, Alliance Management)
Derya Arslan, the Business Development Manager & Chief Marketing Officer, Alliance Management) at Santa Farma, architects the growth strategy through the cultivation of strategic alliances and new market opportunities. Arslan directs the expansion of the company's portfolio by identifying potential collaborations that align with the firm's pharmaceutical expertise. As the Business Development Manager & Chief Marketing Officer, Alliance Management), Arslan manages the complex relationships with external partners to ensure mutual success and long-term value creation. This role involves analyzing market data to pinpoint areas for potential investment and product diversification. Derya Arslan coordinates with the broader leadership team to integrate these alliances into the company's existing operational framework. By focusing on the development of new business channels, the Business Development Manager & Chief Marketing Officer, Alliance Management) strengthens the company's market position. Arslan ensures that every partnership supports the overarching goal of providing innovative healthcare solutions to professionals across the region.
Explore Leadership Teams in Manufacturing
Founded in 1945 and headquartered in Mandaluyong, Philippines Unilab is a manufacturer of pharmaceuticals and other similar products.
Company Leadership SB
RG
MM
RS
Cohance is a global Contract Development and Manufacturing Organization (CDMO) specializing in Antibody Drug Conjugates (ADCs), Nucleic Acid Chemistry, and Small Molecules. The company offers a wide range of services including API development, manufacturing, and clinical analytical services, aimed at accelerating the pipeline for pharmaceutical innovators. With a commitment to sustainability and quality, Cohance partners with clients to provide integrated solutions from discovery to commercial scale. Their expertise and innovative approach make them a trusted partner for complex molecule development and manufacturing needs.
Company Leadership
YD
SS
RS
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership TK

TN
MF
TriRx Pharmaceuticals is a contract development and manufacturing organization specializing in both non-sterile and sterile products, including animal health injectables and packaging solutions. The company offers a wide range of capabilities such as development and analytics, sterile and non-sterile manufacturing, and packaging services. With facilities located in Huntsville, Alabama, and Segré, France, TriRx aims to support customers' commercialization efforts across global markets. Their target clients include pharmaceutical companies looking for advanced solutions to bring their products to market.
Company Leadership TT
JS
KL
RM